![PDF) The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use PDF) The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use](https://i1.rgstatic.net/publication/341515122_The_Use_of_Risperidone_in_Behavioral_and_Psychological_Symptoms_of_Dementia_A_Review_of_Pharmacology_Clinical_Evidence_Regulatory_Approvals_and_Off-Label_Use/links/5ec7e1ed299bf1c09ad4769f/largepreview.png)
PDF) The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
![Figure 10, Head-to-head studies: olanzapine or quetapine versus risperidone—psychosis - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf Figure 10, Head-to-head studies: olanzapine or quetapine versus risperidone—psychosis - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK66085/bin/resultsf9.jpg)
Figure 10, Head-to-head studies: olanzapine or quetapine versus risperidone—psychosis - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf
![Frontiers | The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use | Pharmacology Frontiers | The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use | Pharmacology](https://www.frontiersin.org/files/Articles/485120/fphar-11-00596-HTML-r1/image_m/fphar-11-00596-t001.jpg)
Frontiers | The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use | Pharmacology
![Figure 11, Dementia head-to-head studies: olanzapine or quetapine versus risperidone—agitation - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf Figure 11, Dementia head-to-head studies: olanzapine or quetapine versus risperidone—agitation - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK66085/bin/resultsf10.jpg)
Figure 11, Dementia head-to-head studies: olanzapine or quetapine versus risperidone—agitation - Off-Label Use of Atypical Antipsychotics: An Update - NCBI Bookshelf
Law Firm McSweeney / Langevin Investigating the Alleged Connection between Off-Label Use of Risperdal and Gynecomastia
![Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program](https://effectivehealthcare.ahrq.gov/sites/default/files/5-14-2010_2-16-55_pm.png)
Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
![Off -Label Use of Atypical Antipsychotic Drugs - Comparative Effectiveness Review Summary Guides for Clinicians - NCBI Bookshelf Off -Label Use of Atypical Antipsychotic Drugs - Comparative Effectiveness Review Summary Guides for Clinicians - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK45281/bin/clinantipsychfu4.jpg)
Off -Label Use of Atypical Antipsychotic Drugs - Comparative Effectiveness Review Summary Guides for Clinicians - NCBI Bookshelf
![Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials - Journal of Clinical Epidemiology Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4f82c2fd-c14f-43b3-9a49-99b8f2c83d98/gr1.jpg)
Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials - Journal of Clinical Epidemiology
![Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System | Psychiatric Services Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System | Psychiatric Services](https://ps.psychiatryonline.org/cms/10.1176/ps.2009.60.9.1175/asset/images/medium/jx06t1.jpeg)